Cargando…
Osteopontin and Transplantation: Where Are We Now?
Organ transplantation represents the optimal therapeutic tool for patients with end-stage organ failure. Hematopoietic stem cell transplantation (HSCT) is likewise an effective therapy for a wide range of malignant and non-malignant diseases. Better understanding of transplantation immunology and th...
Autor principal: | Kaleta, Beata |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139897/ https://www.ncbi.nlm.nih.gov/pubmed/34019147 http://dx.doi.org/10.1007/s00005-021-00617-6 |
Ejemplares similares
-
Onchodermatitis: Where Are We Now?
por: Murdoch, Michele E.
Publicado: (2018) -
Role of Osteopontin in Systemic Lupus Erythematosus
por: Kaleta, Beata
Publicado: (2014) -
Where are we now and where are we headed?
por: Langan, Ewan A.
Publicado: (2023) -
Aging with Down Syndrome—Where Are We Now and Where Are We Going?
por: Alldred, Melissa J., et al.
Publicado: (2021) -
Immunotherapies in Genitourinary Oncology: Where Are We Now? Where Are We Going?
por: Jang, Albert, et al.
Publicado: (2021)